BioNexus Gene Lab Corp (BGLC) Stock
BioNexus Gene Lab stock price chart
BGLC stock quote & key statistics
BioNexus Gene Lab annual financials
Income statement →| Fiscal year | Revenue | Net income | EPS |
|---|---|---|---|
| FY2025 | $7.4M | -$3.0M | -$1.29 |
| FY2024 | $9.5M | -$1.6M | -$0.89 |
| FY2023 | $9.8M | -$2.6M | -$1.61 |
| FY2022 | $10.9M | -$355,966 | -$0.25 |
| FY2021 | $13.4M | $751,571 | $0.27 |
Fiscal year ending December 31. Source: company filings via EODHD.
About BioNexus Gene Lab Corp
BioNexus Gene Lab Corp., together with its subsidiaries, focuses on the sale of chemical raw materials for the manufacture of industrial, medical, appliance, aero, automotive, mechanical, and electronic products in Malaysia, Indonesia, Vietnam, and other countries in Southeast Asia. The company operates through three segments: Trading of Industrial Chemicals; Provision for Genomic Screening Services; and Investment Holding.
It offers various chemical raw material products, including polyester resin SHCP 268, a thixotropic, quick-curing unsaturated polyester resin suitable as a general-purpose resin; polyester resin 9509, a general-purpose material used in the production of marine boats and water slides; and polyester resin 2802, which is used as a component in the pultrusion process. The company's products are used in producing various finished goods, such as handrails, bench tops, and automotive and aero parts; paneling for hospital, laboratory, and industrial clean rooms; and covers for various instruments used in manufacturing.
It develops and provides non-invasive liquid biopsy tests for the early detection of biomarkers. BioNexus Gene Lab Corp. was incorporated in 2017 and is based in Kuala Lumpur, Malaysia.
BioNexus Gene Lab stock FAQ
What is the BioNexus Gene Lab stock ticker symbol?
BioNexus Gene Lab Corp trades on the NASDAQ under the ticker symbol BGLC.
What sector and industry is BioNexus Gene Lab in?
BioNexus Gene Lab Corp is classified in the Basic Materials sector, Specialty Chemicals industry.
How many employees does BioNexus Gene Lab have?
BioNexus Gene Lab Corp has about 19 full-time employees.
What were BioNexus Gene Lab's revenue and earnings last fiscal year?
BioNexus Gene Lab reported revenue of $7.4M and net income of -$3.0M in fiscal 2025, with earnings per share of -$1.29. Revenue declined 21.9% from the prior year.
When did BioNexus Gene Lab go public?
BioNexus Gene Lab stock began trading on September 16, 2020.
Specialty Chemicals stocks
All Basic Materials stocks →- ALBAlbemarle
- APDAir Products
- AVNTAvient
- AXTAAxalta Coating Systems
- CBTCabot
- CCChemours
- CLMTCalumet
- DDDuPont
- ECLEcolab
- EMNEastman Chemical
- ESIElement Solutions
- FULH.B. Fuller
- IFFIFF
- LINLinde
- LYBLyondellBasell
- MATVMativ
- MTXMinerals Technologies
- NEUNewMarket
- PPGPPG
- RPMRPM International
- SCLStepan
- SHWSherwin-Williams
- SOLSSolstice Advanced Materials
- WLKWestlake